Global AIDS trial denied patients as U.S. balks at generic drug use

Article Abstract:

The progress of a major international clinical trial, known as Strategies for Management of Anti-Retroviral Therapy (SMART), which is sponsored, by the U.S. National Institute of Allergy and Infectious Diseases (NIAID) is delayed by opposition to generic AIDS drugs from United States. People from South America and Thailand were not allowed to participate in SMART as they are all taking generic versions of brand-name AIDS medicines which are not approved by the U.S. Food and Drug Administration (FDA).

Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Generic Drugs, Usage, Prevention, Clinical trials, AIDS (Disease), United States. National Institute of Allergy and Infectious Diseases

---

Global vaccine project gets a shot in the arm

Article Abstract:

The Seattle-based Bill and Melinda Gates Foundation and the Norwegian government announced ten-year grants of $750 million and $290 million respectively to the Global Alliance for Vaccines and Immunization (GAVI). Although this is a significant amount, additional $8-10 billion would be needed by 2015 just to get existing vaccines out to the children who need them.

Government domestic functions, Norway, HEALTH SERVICES, All Other Miscellaneous Ambulatory Health Care Services, Vaccination & Immunization, Vaccination, Bill and Melinda Gates Foundation, Health policy

---

AIDS research cut to pay for anthrax vaccine

Article Abstract:

Plans are drafted to skim money from research grant programmes to pay for the rapid production of an anthrax vaccine. Director of AIDS research, Daniel Kurtizkes is of the view that they don't mind spending money on research of better anthrax vaccine, but funding the research through raiding AIDS budget will be a matter to be protested.

Science & research, Research, Research grants, Research funding, Anthrax vaccine, Anthrax vaccines

Similar abstracts:

• Abstracts: Removal of rival sperm during copulation in a beetle, Tenebrio molitor. Number of mating males and mating interval affect last-male sperm precedence in Tenebrio molitor L
• Abstracts: Global fund changes tack on malaria therapy. The farmyard drug store. Raiding the medicine cabinet
• Abstracts: Shaking the foundations. Welcome to the dark side. Cosmologists cluster to plot course towards dark energy
• Abstracts: Genomics on the brain. Youthful duo snags a swift Nobel for RNA control of genes
• Abstracts: Inheritance of a pre-inactivated paternal X chromosome in early mouse embryos. Complicity of gene and pseudogene

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.